Episode 134: Nurse Innovators Increase Access to Biomarker Testing During ONS Hackathon

ONS members Meghan Coleman, DNP, CRNP, and Alison McDaniel, BSN, RN, OCN®, join Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss their Evidence-Based Quality Understanding in Pathology (EQUIP) project to solve unequal access to germline and somatic biomarker testing, which earned first place in the inaugural ONS Hackathon. The ONS Hackathon took place over two weeks in November 2020 and gave nurses a platform to develop innovative ways to address challenges in the delivery of quality cancer care. For more information, read the ONS Voice article linked in the episode notes. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by December 18, 2022. The planners and faculty for this episode have no conflicts to disclose, and the episode has no commercial support. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode: The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities. ONS Voice article: An Oncology Nurse's Primer on Genomics and Biomarker Terminology ONS Voice article: Winning Team Reduces Disparities to Biomarker Testing in First-Ever ONS Hackathon Clinical Journal of Oncology Nursing article: Shifting to a Biomarker Paradigm Across Cancer Care ONS Genomics and Precision Oncology Learning Library American Cancer Society information on cancer biomarker testing American Society for Clinical Pathology College of American Pathologists National Comprehensive Cancer Network (NCCN) Biomarkers Compendium NCCN additional information on biomarker testing